Exchange: NASDAQ·Updated 07:59 PM EDT
News
all
press releases
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., Aug. 12, 2026 U.S. Food and Drug Administration (FDA) review of Biologics License Application...
PR Newswire
More News
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Zacks
INOVIO to Report Second Quarter Financial Results on August 12, 2026
INOVIO to Report Second Quarter Financial Results on August 12, 2026 INOVIO to Report Second Quarter Financial Results on August 12, 2026 PR Newswire PLYMOUTH MEETING, Pa., Aug. 4, 2026 PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on...
PR Newswire
INOVIO Announces Pricing of $20.0 Million Public Offering
INOVIO Announces Pricing of $20.0 Million Public Offering INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on...
PR Newswire
INOVIO Announces Proposed Public Offering
INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA...
PR Newswire
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...
PR Newswire
INOVIO to Participate in Upcoming Scientific and Investor Conferences
INOVIO to Participate in Upcoming Scientific and Investor Conferences INOVIO to Participate in Upcoming Scientific and Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., May 28, 2026 PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on...
PR Newswire
INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial
The study showed that the treatment helped reverse precancerous changes in the cervix and clear the high-risk HPV virus that causes them in many patients.
Stocktwits
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China PR Newswire...
PR Newswire
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call
read more...
Benzinga

Advertisement|Remove ads.